| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2358908A1 Bone stimulating factor |
| 07/19/2000 | EP1019528A1 Method for assaying proteolytic enzymes using fluorescence-quenched substrates |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019095A1 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019070A1 Bradykinin analogs as selective inhibitors of cell activation |
| 07/19/2000 | CN1054543C Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090588 Simple and inexpensive process to produce large amounts by inoculating bacteria with inactivated virus, allowing virus to be incorporated into bacteria, contacting with amino acid source to initiate production of pyomelanin and recovering |
| 07/18/2000 | CA2087087C Molecules for iontophoretic delivery |
| 07/13/2000 | WO2000040725A1 Screening method |
| 07/13/2000 | WO2000040602A1 Binding molecules for human factor viii and factor viii-like proteins |
| 07/13/2000 | WO2000040597A1 Method and composition for angiogenesis inhibition |
| 07/13/2000 | WO2000021987A3 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 07/13/2000 | WO2000020445A3 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/13/2000 | WO2000018801A3 Ncam binding compounds |
| 07/13/2000 | WO2000018351A3 Aglyco products and methods of use |
| 07/13/2000 | WO1999060016A3 Antimicrobial cationic peptide derivatives of bactenecin |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | CA2356412A1 Screening method |
| 07/13/2000 | CA2354599A1 Binding molecules for human factor viii and factor viii-like proteins |
| 07/12/2000 | EP1018344A2 HLA-restricted hepatitis B virus CTL epitopes |
| 07/12/2000 | EP1017719A1 Secreted proteins and polynucleotides encoding them |
| 07/12/2000 | EP1017714A1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 07/12/2000 | EP1017713A1 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 07/12/2000 | EP1017712A1 Ucp3 genes |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | EP0635027B1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis |
| 07/12/2000 | EP0580694B1 Production of phosphopeptides from casein |
| 07/12/2000 | EP0413762B1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 07/12/2000 | CN1260006A Complex formation between dsDNA and oligomer of heterocycles |
| 07/12/2000 | CN1259959A GnRh antagonists being modified in positions 5 and 6 |
| 07/12/2000 | CN1259958A Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 07/11/2000 | US6087336 Peptide derivatives useful in treating autoimmune diseases |
| 07/11/2000 | US6087334 Anti-diabetic peptides |
| 07/11/2000 | US6087325 Peptide-lipid conjugates |
| 07/11/2000 | US6087186 Synthetic library of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer; for drug screening |
| 07/11/2000 | US6087110 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| 07/11/2000 | US6087109 Antisense agent which associated with a heat stable toxin receptor; for diagnosis and prevention of intestinal cancers in humans; anticarcinogenic agents . |
| 07/11/2000 | US6086895 Treatment with proteins and polypeptides |
| 07/11/2000 | US6086849 Reagent for preparing a scintigraphic imaging agent, comprising a specific binding peptide having a radiolabel binding moiety that forms a neutral complex when bound to a radioisotope |
| 07/06/2000 | WO2000039156A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/06/2000 | WO2000039155A1 PENICILLINS AS PHARMACEUTICALS FOR THE DOWNREGULATION OF IFNη PRODUCTION |
| 07/06/2000 | WO2000038733A1 Peptidic product, process and composition |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2356186A1 Penicillins as pharmaceuticals for the downregulation of ifn.gamma. production |
| 07/05/2000 | EP1016672A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 07/05/2000 | EP1015884A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 07/05/2000 | EP1015495A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
| 07/05/2000 | EP1015028A2 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 07/05/2000 | EP1015013A1 TREATMENTS FOR NEUROTOXICITY IN ALZHEIMER'S DISEASE BY beta-AMYLOID PEPTIDES |
| 07/05/2000 | EP1015012A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 07/05/2000 | EP1015007A1 Analogs of peptide yy and uses thereof |
| 07/05/2000 | EP0702691B1 New thiodepsipeptide isolated from a marine actinomycete |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/04/2000 | US6084156 Plants producing lytic peptides |
| 07/04/2000 | US6084062 Polypeptides that bind to tissue plasminogen activator (tPA) |
| 07/04/2000 | US6083917 Farnesyltransferase inhibitor peptide having specified tetrapeptide sequence |
| 07/04/2000 | US6083915 Method for treating liver cancer |
| 07/04/2000 | US6083914 Antithrombotic peptides |
| 07/04/2000 | US6083913 Peptides and compounds that bind to a thrombopoietin receptor |
| 07/04/2000 | US6083900 Use of an organopolysiloxane for the fixing and/or sustained release of perfume |
| 07/04/2000 | US6083748 Antibodies which specifically bind to a novel κ/μ-like protein tyrosineospatase, PTPλ, and hybridoma cell lines producing the same |
| 07/04/2000 | US6083486 Intramolecularly-quenched near infrared fluorescent probes |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |
| 06/28/2000 | EP1013764A1 Immunomodulators |
| 06/28/2000 | EP1013761A2 Humanized chimeric antibody directed against ganglioside GD3 |
| 06/28/2000 | EP1013664A1 Antigenic determinants for drug-specific T lymphocytes from drug-allergic patients |
| 06/28/2000 | EP1013662A1 Reaction products between carboxylic acid and amino acid or amino acid condensate and process for producing the same |
| 06/28/2000 | EP1012741A1 Small molecule mimetics of erythropoietin |
| 06/28/2000 | EP1012247A1 Short peptides which selectively modulate intracellular signalling |
| 06/28/2000 | EP1012189A1 Treatment of obesity |
| 06/28/2000 | EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 06/28/2000 | EP1012185A1 Retro-inverso neurotrophic and analgesic peptides |
| 06/28/2000 | EP1012180A2 Hepatitis c inhibitor peptide analogues |
| 06/28/2000 | EP1012178A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 06/28/2000 | EP1012175A1 A peptide with an affinity for clotting factor viii |
| 06/28/2000 | EP1012174A1 Nik proteins, nucleic acids and methods |
| 06/28/2000 | EP1012173A1 Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
| 06/28/2000 | EP1012172A1 Acylated peptide cytolytic peptide inhibitors |
| 06/28/2000 | EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
| 06/28/2000 | EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 06/28/2000 | EP1011736A2 Polymers |
| 06/28/2000 | EP1011716A4 Neuromedin b receptor antagonists |
| 06/28/2000 | EP1011716A1 Neuromedin b receptor antagonists |
| 06/28/2000 | EP1011704A1 Tumor necrosis factor receptor-derived peptide analogues |
| 06/28/2000 | CN1257871A Somatostatin polypeptide analog and its application |
| 06/27/2000 | US6080719 Treatment or prophylaxis of allergies and infections and for inhibiting the binding of interleukin-4 (il-4) to the il-4 receptor |
| 06/27/2000 | US6080398 Chemokines modified by truncation of from 2 to 8 amino acids from the amino terminus of the corresponding mature chemokine selected from kc, gro-beta, gro-gamma, and gro-alpha; lower dose needed, less toxicity |
| 06/27/2000 | CA1341039C Analogues of lhrh allowing increased antigenicity through conjugation |
| 06/22/2000 | WO2000036136A1 Metallopeptide combinatorial libraries and applications |